Camber expands its portfolio with Cisatracurium Besylate Injection, USP [sis-AT-ra-KURE-ee-um], generic to Nimbex®, broadening access […]
Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
Currently browsing: News
Camber Welcomes Summer 2026 Intern Class
Pictured above (left to right): Frank Woodward, Avyan Illapakurthy, Matthew Oliveras, Ella Burgio, Shreya Domakonda, […]
Camber Launches 5 Generics in May
In May 2026, Camber Pharmaceuticals strengthened its portfolio with the launch of five new generic […]
Camber Launches 9 New Generics in Q1 2026
Camber started the year off strongly with the addition of 9 new generic products in […]
Camber Attends DCAT Week Alongside Parent Company Hetero
Pictured from left to right: KrishnaMohan Puchakayala, David Smith, Scott Hettenhausen, Susan Ryan, Stuart Messinger, […]
This Month: 4 New Generics from Camber
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launches of Plerixafor Injection, […]
8 Reasons Camber Is a Valued Partner
In an increasingly competitive generics landscape, buyers need partners they can trust for quality, reliability, […]
Camber Launches Pomalidomide Capsules
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Pomalidomide […]
Sodium Oxybate Added to Portfolio
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Sodium […]
Camber Launches Voriconazole for Oral Suspension
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Voriconazole […]